Topic Issue
Reducing LDL Cholesterol to Prevent Atherosclerotic Cardiovascular Disease AUGUST 2018 ĦE VOL. 10 ĦE NO. 5
Coronary Artery Disease Screening in Patients with Type 2 Diabetes APRIL 2018 ĦE VOL. 10 ĦE NO. 3
Latest Insights on the Treatment of Dyslipidemia NOVEMBER 2017 ĦE VOL. 9 ĦE NO. 7
Update in Chronic Heart Failure Treatment NOVEMBER 2016 ĦE VOL. 8 ĦE NO. 7
Gastrointestinal Bleeding in Patients Treated with Novel Oral Anticoagulants: Risk and Prevention SEPTEMBER 2016 ĦE VOL. 8 ĦE NO. 6
The Important Role of Diet in the Management of Hypercholesterolemia and Prevention of Coronary Heart Disease JULY 2016 ĦE VOL. 8 ĦE NO. 5
New Expert Opinion on the Role of Vasodilating Beta-blockers in Hypertension Management JANUARY 2016 ĦE VOL. 8 ĦE NO. 1
Antibiotic Prophylaxis to Prevent Infective Endocarditis NOVEMBER 2015 ĦE VOL. 7 ĦE NO. 6
Role of Probucol in the Current Treatment of Atherosclerosis and Vascular Disease NOVEMBER 2015 ĦE VOL. 7 ĦE NO. 6
Probucol: Reappraisal of an Old Drug for Atherosclerosis MAY 2015 ĦE VOL. 7 ĦE NO. 3
Latest Update on Hypertension Guidelines: Combination Therapy and More NOVEMBER 2014 ĦE VOL. 6 ĦE NO. 6
An Update on Transcatheter Aortic Valve Implantation SEPTEMBER 2014 ĦE VOL. 6 ĦE NO. 5
An Update in the Management of Atrial Fibrillation JULY 2014 ĦE VOL. 6 ĦE NO. 4
Update on the Use of Angiotensin Receptor Blockers in Hypertension: A Focus on Azilsartan Medoxomil JUNE 2014 ĦE VOL. 6 ĦE NO. 3
Updates on Management of Coronary Artery Disease DECEMBER 2013 ĦE VOL. 5 ĦE NO. 7
Blood Pressure Variability: Is It Important and How Can We Assess It? DECEMBER 2013 ĦE VOL. 5 ĦE NO. 7
Cardiovascular Risk Factors, Morbidity and Mortality in Psoriasis NOVEMBER 2013 ĦE VOL. 5 ĦE NO. 6
Heart Rate Reduction as a Goal in the Management of Cardiovascular Risk MARCH 2013 ĦE VOL. 5 ĦE NO. 2
Advances in the Management of Coronary Artery Disease DECEMBER 2012 ĦE VOL. 4 ĦE No. 7
Contemporary Guidelines on Cardiovascular Disease Prevention and Updated Recommendations on the Use of Antithrombotics SEPTEMBER 2012 ĦE VOL. 4 ĦE NO. 5
Primary Prevention of Sudden Cardiac Death MAY 2012 ĦE VOL. 4 ĦE NO. 3
Hypertension and Atrial Fibrillation MAY 2012 ĦE VOL. 4 ĦE NO. 3
The Role of Combination Therapy in the Management of Hypertension MAY 2012 ĦE VOL. 4 ĦE NO. 3
Cardiovascular Risk in Patients With Psoriatic Arthritis JANUARY 2012 ĦE VOL. 4 ĦE NO. 1
Management of Adverse Gastrointestinal Events in Patients on Antiplatelet Therapy, Part II: Gastrointestinal Bleeding Induced by Clopidogrel or Dual Antiplatelet Therapy JANUARY 2012 ĦE VOL. 4 ĦE NO. 1
Managing Atrial Fibrillation to Reduce Mortality and Morbidity DECEMBER 2011 ĦE VOL. 3 ĦE NO. 7
Niacin for the Treatment of Dyslipidaemia and Atherosclerosis JULY 2011 ĦE VOL. 3 ĦE NO. 4
Management of Adverse Gastrointestinal Events in Patients on Antiplatelet Therapy, Part I: Gastrointestinal Bleeding Induced by Low-dose Aspirin MARCH 2011 ĦE VOL. 3 ĦE NO. 2
Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction MARCH 2011 ĦE VOL. 3 ĦE NO. 2
Treatment of Left Main Disease in 2011 JANUARY 2011 ĦE VOL. 3 ĦE NO. 1
Angiotensin Receptor Blockers - Across the Cardiovascular Continuum DECEMBER 2010 ĦE VOL. 2 ĦE NO. 8
Case Study: A 75-year-old Gentleman With Recurrent Palpitation SEPTEMBER 2010 ĦE VOL. 2 ĦE NO. 6
Sleep Apnoea and Arrthymias MARCH 2010 ĦE VOL. 2 ĦE NO. 2
Coronary Artery Disease: Pills, Stents or Surgeon's Knife? DECEMBER 2009 ĦE VOL. 1 ĦE NO. 6
The Post-cardiac Arrest Syndrome JULY 2009 ĦE VOL. 1 ĦE NO. 3
Update on Management of Heart Failure JANUARY 2009 ĦE VOL. 1 ĦE NO. 1
Approaches to Carotid Stenosis JANUARY 2009 ĦE VOL. 1 ĦE NO. 1
Utilizing Cardiac CT for the Detection of Coronary Artery Disease JANUARY 2009 ĦE VOL. 1 ĦE NO. 1
Heart Disease Does not Equate Coronary Artery Disease JANUARY 2009 ĦE VOL. 1 ĦE NO. 1
This website is restricted for use by medical doctors only.
Disclaimer
| Terms of use | Privacy Statement
Copyright © 2006 The Society of Physicians of Hong Kong.